Fisher Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Fisher Asset Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Sell	53,213 -6,151	-10%	-$312K	﹤0.01%	544
2026 Q1	$3.17M	Sell	59,364 -31,162	-34%	-$1.83M	﹤0.01%	514
2025 Q4	$5.63M	Sell	90,526 -7,934	-8%	-$490K	﹤0.01%	455
2025 Q3	$5.92M	Sell	98,460 -7,464	-7%	-$457K	﹤0.01%	459
2025 Q2	$6.64M	Sell	105,924 -41,142	-28%	-$2.47M	﹤0.01%	449
2025 Q1	$8.85M	Sell	147,066 -1,001,666	-87%	-$62.2M	﹤0.01%	424
2024 Q4	$67M	Sell	1,148,732 -66,852	-5%	-$3.97M	0.03%	191
2024 Q3	$72M	Sell	1,215,584 -706,134	-37%	-$40.3M	0.03%	186
2024 Q2	$108M	Sell	1,921,718 -84,919	-4%	-$4.75M	0.05%	159
2024 Q1	$118M	Sell	2,006,637 -69,108	-3%	-$3.9M	0.05%	159
2023 Q4	$112M	Sell	2,075,745 -110,248	-5%	-$5.39M	0.06%	161
2023 Q3	$106M	Sell	2,185,993 -97,349	-4%	-$5.18M	0.06%	187
2023 Q2	$129M	Buy	2,283,342 +27,088	+1%	+$1.49M	0.07%	178
2023 Q1	$122M	Buy	2,256,254 +21,037	+0.9%	+$1.12M	0.07%	178
2022 Q4	$118M	Buy	2,235,217 +126,884	+6%	+$6.44M	0.08%	165
2022 Q3	$99.5M	Buy	2,108,333 +1,086,084	+106%	+$56.4M	0.07%	168
2022 Q2	$51.6M	Buy	1,022,249 +95,812	+10%	+$5.22M	0.04%	222
2022 Q1	$56.5M	Buy	926,437 +62,822	+7%	+$3.75M	0.03%	226
2021 Q4	$56.9M	Buy	863,615 +52,929	+7%	+$3.39M	0.03%	231
2021 Q3	$50.9M	Buy	810,686 +47,360	+6%	+$3.02M	0.03%	227
2021 Q2	$45.9M	Buy	763,326 +59,238	+8%	+$3.43M	0.03%	238
2021 Q1	$38.8M	Buy	704,088 +52,386	+8%	+$2.91M	0.03%	255
2020 Q4	$35.6M	Buy	651,702 +55,572	+9%	+$2.9M	0.03%	253
2020 Q3	$29.8M	Buy	596,130 +10,842	+2%	+$525K	0.03%	242
2020 Q2	$25.8M	Buy	585,288 +481,980	+467%	+$20.6M	0.03%	257
2020 Q1	$3.88M	Buy	+103,308	New	+$4.35M	﹤0.01%	378
2019 Q3	–	Sell	-5,238	Closed	-$210K	–	848
2019 Q2	$210K	Buy	+5,238	New	+$198K	﹤0.01%	793

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Fisher Asset Management's IHI Position: Q2 2026 in Review

Fisher Asset Management reduced its iShares US Medical Devices ETF (IHI) stake by 10% in Q2 2026, selling an estimated $312K and leaving 53,213 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Fisher Asset Management first reported a position in IHI in Q2 2019 and has held it in 27 quarters since. The position peaked at $129M in Q2 2023. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Fisher Asset Management held 53,213 shares of iShares US Medical Devices ETF worth $2.63M as of Q2 2026.
Fisher Asset Management sold 6,151 iShares US Medical Devices ETF shares in Q2 2026, an estimated $312K.
iShares US Medical Devices ETF made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #544 holding.
Fisher Asset Management first reported a position in iShares US Medical Devices ETF in Q2 2019 and has held it in 27 quarters since.
Fisher Asset Management's iShares US Medical Devices ETF position peaked at $129M in Q2 2023.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.